Sangivamycin (OyaGen) | m-entrepreneurship.com

Product Name :
Sangivamycin (OyaGen)

Search keywords :
Sangivamycin

drugId :
null

Target Vo:
Protein kinase C

Target Vo Short Name :
PKC

Moa_Name:
Protein kinase C inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
OyaGen Inc

Active Company_Name :
OyaGen Inc

Active Indication_Name:
Hemorrhagic Fever, Ebola

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Interferon alfa Epigenetic Reader Domain
Acetyl-Histone H3 (Lys27) Rabbit mAb MedChemExpress
RNA Polymerase II Subunit B1 Antibody: RNA Polymerase II Subunit B1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 217 kDa, targeting to RNA Polymerase II Subunit B1. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts